SCHEMBL2365056

SCHEMBL2365056

C[C@@H]1CCN(C(=O)Nc2ccon2)C[C@@H]1N(c1ccnc2[nH]ccc12)S(C)(=O)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 19/20 0.44
JAK2 O60674 10/20 0.43
JAK1 P23458 9/20 0.43
TYK2 P29597 4/20 0.42
PKN2 Q16513 3/20 0.41
AURKB Q96GD4 2/20 0.41
ROCK2 O75116 2/20 0.39
MARK3 P27448 2/20 0.39
PRKCD Q05655 2/20 0.39
STK3 Q13188 2/20 0.39
ROCK1 Q13464 2/20 0.39
CAMK2D Q13557 2/20 0.39
LRRK2 Q5S007 2/20 0.39
MARK2 Q7KZI7 2/20 0.39
MAP4K3 Q8IVH8 1/20 0.39
MAP4K5 Q9Y4K4 1/20 0.39
DCLK1 O15075 1/20 0.39
ABL1 P00519 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10080257 0.88 JAK3 (0.53) JAK3JAK2JAK1TYK2PKN2
SCHEMBL353135 0.88 JAK3 (0.53) JAK3JAK2JAK1TYK2PKN2
SCHEMBL4068614 0.79 JAK3 (0.68) JAK3JAK2JAK1TYK2PKN2
SCHEMBL10079943 0.77 JAK3 (0.55) JAK3JAK2JAK1TYK2PKN2
SCHEMBL353054 0.77 JAK3 (0.55) JAK3JAK2JAK1TYK2PKN2
SCHEMBL350927 0.74 JAK2 (0.60) JAK3JAK2JAK1TYK2PKN2
SCHEMBL10080592 0.74 JAK2 (0.60) JAK3JAK2JAK1TYK2PKN2
SCHEMBL352844 0.73 JAK3 (0.56) JAK3JAK2JAK1TYK2PKN2
SCHEMBL10080258 0.73 JAK3 (0.56) JAK3JAK2JAK1TYK2PKN2
SCHEMBL10080553 0.73 JAK3 (0.56) JAK3JAK2JAK1TYK2PKN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349260-A1 JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES Incyte Corporation (US) 2011-08-03 EP disclosed
WO-2010039939-A1 JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES INCYTE CORPORATION (US) 2010-04-08 WO disclosed